Results of the Alexander Project: A continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens

Diagnostic Microbiology and Infectious Disease

Volumn 25, Issue 4, 1996, Pages 169-181

  Gruneberg R N ^a   Felmingham, D ^b   Acar, J ^c   Lemozy, J ^c   Bauernfeind, A ^c   Grimm, H ^c   Schito, G C ^c   Russo, G ^c   Baquero, F ^c   Linares Louzao, J ^c   Grutineberg R ^c   Murphy, P ^c   Neu, H ^c   Chin, U X ^c   Washington, J ^c   Berk, S ^c   Pfaller, M ^c   Sewell, D ^c   Doern, G ^c  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b GR Micro Ltd   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFIXIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; CONTROLLED STUDY; EUROPE; HAEMOPHILUS INFLUENZAE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MORAXELLA CATARRHALIS; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ANTI-BACTERIAL AGENTS; BACTERIA; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE; EUROPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTICENTER STUDIES; RESPIRATORY TRACT INFECTIONS; UNITED STATES;

EID: 0030221396     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(96)00135-6     Document Type: Conference Paper

References (38)

1. Appelbaum PC, Bhamjee A, Scragg JN, Hallett AF, Bowen AJ, Cooper RC (1977) Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 2:995-997.
2. Baquero F (1995) Pneumococcal resistance to β-lactam antibiotics: A global geographic overview. Microb Drug Resist 1:115-120.
3. Berk SL (1990) From Micrococcus to Moraxella: The re-emergence of Branhamella catarrhalis. Arch Intern Med 150:2254-2257.
4. Catlin BN (1990) Branhamella catarrhalis an organism gaining respect as a pathogen. Clin Microbiol Rev 3:293-320.
5. Coffey TJ, Dowson CG, Daniels M, Zhou J, Martin C, Spratt BG, Musser JM (1995) Genetics and molecular biology of β-lactam-resistant pneumococci. Microb Drug Resist 1:29-34.
6. Cunliffe NA, Emmanuel FXS, Thomson CJ (1995) Lower respiratory tract infection due to ciprofloxacin resistant Moraxella catarrhalis. J Antimicrob Chemother 36:273-274.
7. Dabernat H, Seguy M, Delmas C (1994) Situation 1993 de la résistance aux antibiotiques chez Haemophilus influenzae en France. Méd Mal Infect 24:1244-1247.
8. Daum RS, Murphey-Corb M, Shapira E, Dipp S (1988) Epidemiology of Rob β-lactamase among ampicillin-resistant Haemophilus influenzae isolates in the United States. J Infect Dis 157:450-455.
9. Doern GV, Jorgensen JH, Thornsberry C, Preston DA, and the Haemophilus influenzae Surveillance Group (1986) Haemophilus influenzae Surveillance Group: Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: A collaborative study. Diagn Microbiol Infect Dis 4:95-107.
10. Doern GV, Jorgensen JH, Thornsberry C, Preston DA, Tubert T, Redding JS, Maher LA (1988) National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother 32:180-185.
11. Doern GV (1992) In vitro susceptibility testing of Haemophilus influenzae: Review of new national committee for clinical laboratory standards recommendations. J Clin Microbiol 30:3035-3038.
12. Doern GV (1994) Emergence of antimicrobial resistance with Streptococcus pneumoniae, Haemophilus influenzae and Neisseria species. Abstract Session 91 Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando 1994. Washington, DC: ASM p 288.
13. Doern GV and the Alexander Project Collaborative Group (1996) Antimicrobial resistance among lower respiratory tract isolates of Haemophilus influenzae - results of a 1992-93 western European and United States collaborative surveillance study. J Antimicrob Chemother 38(Suppl. A):59-69.
14. Fass RJ (1993) Etiology and treatment of community-acquired pneumonia in adults: An historical perspective. J Antimicrob Chemother 32(Suppl. A):17-27.
15. Felmingham D (1995) Antibiotic resistance. Do we need new therapeutic approaches? Chest 8:70S-78S.
16. Felmingham D & Gruneberg RN and the Alexander Project Collaborative Group (1996) A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993 - the Alexander Project. J Antimicrob Chemother 38(Suppl. A):1-57.
17. Fenoll A, Bourgon CM, Muñoz R, Vicios O, Casal J (1991) Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain. Rev Infect Dis 13:56-60.
18. Fung CP, Yeo SF, Livermore DM (1994) Susceptibility of Moraxella catarrhalis isolates to β-lactam antibiotics in relation to β-lactamase pattern. J Antimicrob Chemother 33:215-222.
19. Goldstein FW (1994) Resistance des pneumocoques. Rev Prat 8:1068-1073.
20. Goldstein FW, Acar JF (1995) Epidemiology of resistance in Haemophilus influenzae. Microb Drug Resist 1:131-135.
21. Gould IM, Forbes KJ, Gordon GS (1994) Quinolone resistant Haemophilus influenzae. J Antimicrob Chemother 33: 187-188.
22. Hakenbeck R, Tarpay M, Tomasz A (1980) Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 17:364-371.
23. Hansman D, Bullen MM (1967) A resistant pneumococcus. Lancet 2:264-265.
24. Hosker HSR, Jones GM, Hawkey P (1994) Management of community-acquired lower respiratory tract infection. Br Med J 308:701-705.
25. Jacobs MR, Koornhof HJ, Robins-Browne RM, Stevenson CM, Vermaak ZA, Freiman I, Miller GB, Whitcomb MA, Isaacson M, Ward JI, Austrian R (1978) Emergence of multiply-resistant pneumococci. N Engl J Med 299:735-740.
26. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS (1990) Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 34:2075-2080.
27. Kayser FH, Morenzoni G, Santanam P (1990) The second European collaborative study on the frequency of antimicrobial resistance in Haemophilus influenzae. Eur J Clin Microbiol Infect Dis 9:810-817.
28. Khan W, Ross S, Rodriguez W, Controni G, Saz AR (1974) Haemophilus influenzae type B resistant to ampicillin: A report of two cases. JAMA 229:298-301.
29. Mathies AW Jr. (1972) Penicillins in the treatment of bacterial meningitis. J Roy Coll Physicians Lond 6:139-146.
30. Markowitz SM (1980) Isolation of an ampicillin-resistant non-β-lactamase producing strain of Haemophilus influenzae. Antimicrob Agents Chemother 17:80-83.
31. Mendelman PM, Chaffin DO, Stull TL, Rubens CE, Mack KD, Smith AL (1984) Characterisation of non-β-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother 26:235-244.
32. National Committee for Clinical Laboratory Standards (1995) NCCLS Document M100-S6. Performance Standards for Antimicrobial Susceptibility Testing. Sixth Informational Supplement. Villanova, PA: NCCLS.
33. Powell M, Fah YS, Seymour A, Yuan M, Williams JD (1992) Antimicrobial resistance in Haemophilus influenzae from England and Scotland in 1991. J Antimicrob Chemother 29:547-554.
34. Scriver SR, Walmsley SL, Kau CL, Hoban DJ, Brunton J, McGeer A, Moore TC, Witwicki E, Canadian Haemophilus Study Group, Low DE (1994) Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterisation of their β-lactamases. Antimicrob Agents Chemother 38:1678-1680.
35. Stokes EJ, Ridgway GL, Wren MWD (1993) Laboratory control of chemotherapy. Clinical Microbiology, 7th Edition. London, UK: Edward Arnold pp 234-280.
36. Sykes RB, Matthews M, O'Callaghan CH (1975) R-factor mediated β-lactamase production by Haemophilus influenzae. J Med Microbiol 8:437-441.
37. Tomeh MO, Starr SE, McGowan JE, Terry PM, Nahmias AJ (1974) Ampicillin-resistant Haemophilus influenzae type b infection. JAMA 229:295-297.
38. Van Klingeren B, van Embden JDA, Dessens-Kroon M (1977) Plasmid-mediated chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother 11: 383-387.